UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature

Reviews in endocrine & metabolic disorders, 2021-06, Vol.22 (2), p.337-349

2021

Volltextzugriff (PDF)

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis

Annals of oncology, 2013-02, Vol.24 (2), p.406-411

2013

Volltextzugriff (PDF)

Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study

Annals of oncology, 2010-03, Vol.21 (3), p.655-661

2010

Volltextzugriff (PDF)

Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer

Annals of oncology, 2018-10, Vol.29, p.viii413-viii413

2018

Volltextzugriff (PDF)

A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors

Medicina oral, patología oral y cirugía bucal, 2017-05, Vol.22 (3), p.e342-e348

2017

Volltextzugriff (PDF)

A randomised clinical trial of two docetaxel regimens (weekly 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

British journal of cancer, 2004-12, Vol.91 (12), p.1996-2004

2004

Volltextzugriff (PDF)

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

European journal of cancer (1990), 2011-09, Vol.47 (14), p.2091-2098

2011

Volltextzugriff (PDF)

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

British journal of cancer, 2008-01, Vol.98 (1), p.71-76

2008

Volltextzugriff (PDF)

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

British journal of cancer, 2004-04, Vol.90 (8), p.1521-1525

2004

Volltextzugriff (PDF)

Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case

Digestive and liver disease, 2005-04, Vol.37 (4), p.278

2005

Volltextzugriff (PDF)

F-38 Contrast-enhanced ultrasound and serological biomarkers for early evaluation of clinical outcome of HCC sorafenib treatment

Digestive and liver disease, 2011, Vol.43, p.S104-S104

2011

Volltextzugriff (PDF)

Presacral carcinoid tumourReview of the literature and report of a clinically malignant case

Digestive and liver disease, 2005-04, Vol.37 (4), p.278-281

2005

Volltextzugriff (PDF)

7O Updated results from phase I study of CC-90011 in patients (pts) with solid tumours (STs), including neuroendocrine neoplasms (NENs), and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)

Annals of oncology, 2021-03, Vol.32, p.S4-S4

2021

Volltextzugriff (PDF)

559P Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)

Annals of oncology, 2020-09, Vol.31, p.S482-S483

2020

Volltextzugriff (PDF)

528O CC-90011 in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

Annals of oncology, 2020-09, Vol.31, p.S464-S464

2020

Volltextzugriff (PDF)

Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer

Anti-cancer drugs, 2009-08, Vol.20 (7), p.616-624

2009

Volltextzugriff (PDF)

480 Evidence from the phase III AVADO study reveals no increase in tumour malignant potential following treatment of metastatic breast cancer (mBC) with bevacizumab (BV) and docetaxel (D)

European journal of cancer supplements, 2010, Vol.8 (3), p.199-200

2010

Volltextzugriff (PDF)

Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: A low cost effective regimen

British journal of cancer, 2002-01, Vol.86 (2), p.213-217

2002

Volltextzugriff (PDF)

18O CC-90011 in patients (Pts) with advanced solid tumors (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

Annals of oncology, 2020-03, Vol.31, p.S6

2020

Volltextzugriff (PDF)

1383PD - Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

Annals of oncology, 2019-10, Vol.30, p.v565-v565

2019

Volltextzugriff (PDF)

1383PDPhase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

Annals of oncology, 2019-10, Vol.30, p.v565

2019

Volltextzugriff (PDF)

Survival and quality of life in gastrointestinal tumors: Two different end points?

Annals of oncology, 2001, Vol.12 (suppl-3), p.S31-S36

2001

Volltextzugriff (PDF)

1159PPhase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Journal of clinical oncology, 2024-09

2024

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(193)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis

Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study

Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer

A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors

A randomised clinical trial of two docetaxel regimens (weekly 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case

F-38 Contrast-enhanced ultrasound and serological biomarkers for early evaluation of clinical outcome of HCC sorafenib treatment

Presacral carcinoid tumourReview of the literature and report of a clinically malignant case

7O Updated results from phase I study of CC-90011 in patients (pts) with solid tumours (STs), including neuroendocrine neoplasms (NENs), and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)

559P Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)

528O CC-90011 in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer

480 Evidence from the phase III AVADO study reveals no increase in tumour malignant potential following treatment of metastatic breast cancer (mBC) with bevacizumab (BV) and docetaxel (D)

Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: A low cost effective regimen

18O CC-90011 in patients (Pts) with advanced solid tumors (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

1383PD - Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

1383PDPhase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

Survival and quality of life in gastrointestinal tumors: Two different end points?

1159PPhase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Suchergebnisse filtern